Revolutionary BiVACOR heart device moves to phase 2 of FDA trial
Like all mechanical hearts, BiVACOR currently acts as bridge for patients waiting for a human heart transplant, but its ...
MassDevice14h
First patient enrolled in IDE study of Conformal Medical’s next-gen LAAO device
Conformal Medical today announced on social media that the first U.S. site enrolled a patient in a trial of its next-gen ...
medtechdive15h
Device industry scrambles as FDA job cuts cause delays
The cuts at the FDA’s device center could add “months, if not years” to the time it takes to bring products to market, an ...
MassDevice19h
Data backs Lungpacer Medical’s diaphragm neurostim
Lungpacer Medical today announced positive results from a Phase 1 clinical study evaluating its neurostimulation technology ...
Petri Dish: One Boston biotech shuts down, another bags $90M
In the past week, a Boston biotech led by longtime industry CEO Harvey Berger said it plans to shut down, while another ...